PharmaCielo Statistics

Total Valuation

PharmaCielo has a market cap or net worth of CAD 8.46 million. The enterprise value is 28.84 million.

Market Cap	8.46M
Enterprise Value	28.84M

Important Dates

The next estimated earnings date is Monday, December 1, 2025.

Earnings Date	Dec 1, 2025
Ex-Dividend Date	n/a

Share Statistics

PharmaCielo has 187.98 million shares outstanding. The number of shares has increased by 6.57% in one year.

Current Share Class	187.98M
Shares Outstanding	187.98M
Shares Change (YoY)	+6.57%
Shares Change (QoQ)	+8.17%
Owned by Insiders (%)	8.56%
Owned by Institutions (%)	0.18%
Float	171.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.12
PB Ratio	-0.77
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	8.17
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.69
EV / Sales	10.63
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.09

Current Ratio	0.09
Quick Ratio	0.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.28

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	34.42%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -59.09% in the last 52 weeks. The beta is 1.65, so PharmaCielo's price volatility has been higher than the market average.

Beta (5Y)	1.65
52-Week Price Change	-59.09%
50-Day Moving Average	0.05
200-Day Moving Average	0.07
Relative Strength Index (RSI)	42.31
Average Volume (20 Days)	3,731

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PharmaCielo had revenue of CAD 2.71 million and -7.82 million in losses. Loss per share was -0.04.

Revenue	2.71M
Gross Profit	38,173
Operating Income	-3.79M
Pretax Income	-7.82M
Net Income	-7.82M
EBITDA	-2.80M
EBIT	-3.79M
Loss Per Share	-0.04

Full Income Statement

Balance Sheet

The company has 6,541 in cash and 20.80 million in debt, giving a net cash position of -20.80 million or -0.11 per share.

Cash & Cash Equivalents	6,541
Total Debt	20.80M
Net Cash	-20.80M
Net Cash Per Share	-0.11
Equity (Book Value)	-11.02M
Book Value Per Share	-0.06
Working Capital	-26.53M

Full Balance Sheet

Cash Flow

Operating Cash Flow	1.04M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 1.41%, with operating and profit margins of -139.90% and -288.39%.

Gross Margin	1.41%
Operating Margin	-139.90%
Pretax Margin	-288.39%
Profit Margin	-288.39%
EBITDA Margin	-103.40%
EBIT Margin	-139.90%
FCF Margin	n/a

Dividends & Yields

PharmaCielo does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.57%
Shareholder Yield	-6.57%
Earnings Yield	-92.46%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on January 18, 2019. It was a reverse split with a ratio of 0.083752.

Last Split Date	Jan 18, 2019
Split Type	Reverse
Split Ratio	0.083752

Scores

PharmaCielo has an Altman Z-Score of -18.32 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-18.32
Piotroski F-Score	3